Tyria Saul

  • Electronic Neurostatus-EDSS Increases Quality of Expanded Disability Status Scale (EDSS) Assessments

    Electronic Neurostatus-EDSS Increases Quality of Expanded Disability Status Scale (EDSS) Assessments

    First experience from two phase 3 clinical trials with ofatumumab in relapsing multiple sclerosis using the Web Diary

    Read
  • Effective Body Maps for Precision Symptom Reporting In Clinical Trials

    Effective Body Maps for Precision Symptom Reporting In Clinical Trials

    An eBook covering precision symptom reporting in clinical trials supported by a usability study on the ideal electronic clinical outcome assessment (eCOA) body maps - from design to functionality

    Read
  • Game Technology Opens New Path to Clinical Endpoints - DIA Podcast

    Game Technology Opens New Path to Clinical Endpoints - DIA Podcast

    Dr. Bill Byrom, VP of Product Strategy & Innovation at CRF Health discusses the future of electronic patient reported outcomes (ePRO), mobile accelerometry, & other mobile devices, in clinical trials.

    Read
  • CRF Health Industry Luminaries to Share eSource Expertise in Clinical Trials at DIA 2018

    CRF Health Industry Luminaries to Share eSource Expertise in Clinical Trials at DIA 2018

    CRF Health will interactive workshops and speaker sessions at DIA’s 2018 Global Annual Meeting, June 24-28, Boston, MA. The sessions cover mobile and wearable tech and patient-centricity in trials.

    Read
  • Recognition for CRF Health’s World Class eSource Wins European Award

    Recognition for CRF Health’s World Class eSource Wins European Award

    CRF Health has been recognized as 2018 New Entrant of the Year in Romania’s Regional IT & Outsourcing Industry Awards, otherwise known as the PIN Awards.

    Read
  • CRF Health’s eCOA Solution Selected for Large-Scale Insomnia Study by Innovative European Pharmaceutical Company

    CRF Health’s eCOA Solution Selected for Large-Scale Insomnia Study by Innovative European Pharmaceutical Company

    CRF Health announced that its eCOA solutions have been selected for a significant insomnia trial by a European pharmaceutical company specializing in the discovery and development of small molecules.

    Read
  • loading
    Loading More...